ARCHIVES

Orphan Designation Granted To Advaxis HPV Immunotherapy

This article is from The Cancer Letter archive.

Vol. 37 No. 5 | May 30, 2014

Download PDF Visit The Full Archive

Related Articles

Mason Asks For Better Technology Transfer In Cancer Prevention

October 30, 1992

In Brief: New Presidents Take Office At ONS, ONCC, ARS; Baird Wins Awards; New VP In Houston

July 8, 1994

Holland On The Next 10 Years; Progress In Prevention, Diagnosis, Therapy

March 23, 1984

Clinical Trials: NCI Removes Brooklyn Site From PLCO Trials

October 24, 1997

Economic Analyses Of New Therapies Useful In Phase III Studies, Trialists Say

July 24, 2009

Fox Chase Cancer Center Board Selects Michael Seiden of Dana-Farber/Harvard As New President.

March 23, 2007